DRG 251
Surgical DRGPercutaneous Cardiovascular Procedures without Intraluminal Device without MCC
What is MS-DRG 251?
MS-DRG 251 is a Surgical Medicare Severity Diagnosis Related Group under Major Diagnostic Category 05 (MDC 05) without a significant Complication or Comorbidity. Hospitals use this grouping to determine reimbursement for inpatient stays under Medicare.
Linked ICD-10-PCS Procedure Mappings
- 02570ZK
Destruction of Left Atrial Appendage, Open Approach
BillableSection 0 - 02700ZZ
Dilation of Coronary Artery, One Artery, Open Approach
BillableSection 0 - 02710ZZ
Dilation of Coronary Artery, Two Arteries, Open Approach
BillableSection 0 - 02720ZZ
Dilation of Coronary Artery, Three Arteries, Open Approach
BillableSection 0 - 02730ZZ
Dilation of Coronary Artery, Four or More Arteries, Open Approach
BillableSection 0 - 02B70ZK
Excision of Left Atrial Appendage, Open Approach
BillableSection 0 - 02FP3Z0
Fragmentation of Pulmonary Trunk, Percutaneous Approach, Ultrasonic
BillableSection 0 - 02FP3ZZ
Fragmentation of Pulmonary Trunk, Percutaneous Approach
BillableSection 0 - 02FQ3Z0
Fragmentation of Right Pulmonary Artery, Percutaneous Approach, Ultrasonic
BillableSection 0 - 02FQ3ZZ
Fragmentation of Right Pulmonary Artery, Percutaneous Approach
BillableSection 0 - 02FR3Z0
Fragmentation of Left Pulmonary Artery, Percutaneous Approach, Ultrasonic
BillableSection 0 - 02FR3ZZ
Fragmentation of Left Pulmonary Artery, Percutaneous Approach
BillableSection 0 - 02FS3Z0
Fragmentation of Right Pulmonary Vein, Percutaneous Approach, Ultrasonic
BillableSection 0 - 02FS3ZZ
Fragmentation of Right Pulmonary Vein, Percutaneous Approach
BillableSection 0 - 02FT3Z0
Fragmentation of Left Pulmonary Vein, Percutaneous Approach, Ultrasonic
BillableSection 0 - 02FT3ZZ
Fragmentation of Left Pulmonary Vein, Percutaneous Approach
BillableSection 0 - 02U037Z
Supplement Coronary Artery, One Artery with Autologous Tissue Substitute, Percutaneous Approach
BillableSection 0 - 02U038Z
Supplement Coronary Artery, One Artery with Zooplastic Tissue, Percutaneous Approach
BillableSection 0 - 02U03JZ
Supplement Coronary Artery, One Artery with Synthetic Substitute, Percutaneous Approach
BillableSection 0 - 02U03KZ
Supplement Coronary Artery, One Artery with Nonautologous Tissue Substitute, Percutaneous Approach
BillableSection 0 - 02U137Z
Supplement Coronary Artery, Two Arteries with Autologous Tissue Substitute, Percutaneous Approach
BillableSection 0 - 02U138Z
Supplement Coronary Artery, Two Arteries with Zooplastic Tissue, Percutaneous Approach
BillableSection 0 - 02U13JZ
Supplement Coronary Artery, Two Arteries with Synthetic Substitute, Percutaneous Approach
BillableSection 0 - 02U13KZ
Supplement Coronary Artery, Two Arteries with Nonautologous Tissue Substitute, Percutaneous Approach
BillableSection 0 - 02U237Z
Supplement Coronary Artery, Three Arteries with Autologous Tissue Substitute, Percutaneous Approach
BillableSection 0 - 02U238Z
Supplement Coronary Artery, Three Arteries with Zooplastic Tissue, Percutaneous Approach
BillableSection 0 - 02U23JZ
Supplement Coronary Artery, Three Arteries with Synthetic Substitute, Percutaneous Approach
BillableSection 0 - 02U23KZ
Supplement Coronary Artery, Three Arteries with Nonautologous Tissue Substitute, Percutaneous Approach
BillableSection 0 - 02U337Z
Supplement Coronary Artery, Four or More Arteries with Autologous Tissue Substitute, Percutaneous Approach
BillableSection 0 - 02U338Z
Supplement Coronary Artery, Four or More Arteries with Zooplastic Tissue, Percutaneous Approach
BillableSection 0 - 02U33JZ
Supplement Coronary Artery, Four or More Arteries with Synthetic Substitute, Percutaneous Approach
BillableSection 0 - 02U33KZ
Supplement Coronary Artery, Four or More Arteries with Nonautologous Tissue Substitute, Percutaneous Approach
BillableSection 0 - 02U73JZ
Supplement Left Atrium with Synthetic Substitute, Percutaneous Approach
BillableSection 0 - 02U74JZ
Supplement Left Atrium with Synthetic Substitute, Percutaneous Endoscopic Approach
BillableSection 0 - X2A7358
Intermittent Coronary Sinus Occlusion, Percutaneous Approach, New Technology Group 8
BillableSection X